胰高血糖素样肽-1在消化系统中的病理生理作用
被引量:1
摘要
胰高血糖素样肽(glucagon-like peptide,GLP)-1是一种主要由肠道L细胞分泌的胃肠肽类激素,在消化系统和中枢神经系统中均有发现。GLP-1可作用于胰岛细胞并发挥多种功能,包括刺激胰岛素的生物合成和分泌,抑制胰高血糖素的分泌。GLP-1还可作用于下丘脑和胃肠道,发挥抑制食欲、延缓胃排空及抑制肠道运动等作用。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2012年第3期212-214,共3页
Chinese Journal of Digestion
参考文献20
-
1Orskov C,Rabenhoj L,Wettergren A. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide Ⅰ in humans[J].Diabetes,1994.535-539.
-
2Drucker DJ,Asa S. Glucagon gene expression in vertebrate brain[J].Journal of Biological Chemistry,1988.13475-13478.
-
3Jin SL,Han VK,Simmons JG. Distribution of glucagonlike peptide-1 (GLP-1),glucagon,and glicentin in the rat brain:an immunocytochemical study[J].Journal of Comparative Neurology,1988.519-532.
-
4王宇,高宏凯,张新国.胰高血糖素样肽-1及其受体在调节胰岛β细胞功能方面的作用[J].医学研究杂志,2008,37(2):103-105. 被引量:10
-
5Sugiyama K,Manaka H,Kato T. Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorption[J].Digestion,1994.24-28.
-
6Mulherin AJ,Oh AH,Kim H. Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell[J].Endocrinology,2011.4610-4619.
-
7De León DD,Crutchlow MF,Ham JY. Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus[J].International Journal of Biochemistry & Cell Biology,2006.845-859.
-
8杨桂芳,胡克振.胰高血糖素样肽-1的生理功能及相关药物评价[J].药物流行病学杂志,2008,17(4):224-227. 被引量:6
-
9Wettergren A,Schjoldager B,Mortensen PE. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man[J].Digestive Diseases and Sciences,1993.665-673.
-
10Meier JJ,Gallwitz B,Salmen S. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes[J].Journal of Clinical Endocrinology and Metabolism,2003.2719-2125.
二级参考文献25
-
1崔岱,刘超,唐伟,蒋琳,朱剑,刘翠萍.GLP-1对大鼠胰岛细胞增殖及凋亡的影响[J].中国糖尿病杂志,2007,15(5):310-312. 被引量:13
-
2Kreymann B, Williams G, ghatei MA, et al. Glucagon-like peptide-1 (7-36) : a physiological incretin in man[ J]. Lancet, 1987,2( 8571 ) : 1300-1303
-
3Holst JJ. Glucagon-like poptide 1 ( Glp-1 ) : an intestinal hormone, signaling nutritional abundancc, with an unusual therapeutic potential[ J ]. Trands Endocr Met, 1999,10 (6) :229- 235
-
4Drucker DJ. Glucagon-like peptides:regulators of cell proliferation differentiation and apoptosis [ J ]. Mol Endocrinol, 2003,17(2) :161-171
-
5Schick RR,Zimmermann JP,Vorm WT, et al. Glucagon-like peptide (Glp) -1 - (7-36) -amide: a central suppressor of food intake in rats [ J ]. Gastroenterology, 1992,102 ( suppl 1 ) : A756
-
6Eng J, Kleinman WA, Singh L,et al. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom, further evidence for an exendin receptor on dispersed acini from guinea pig pancrcas [J]. Biol chem, 1992 267:7402-7405
-
7Defronzo RA, Ratner RE, Han J, et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in mefformin-treated patients with type 2 diabetes [ J]. Diabetes care ,2005,28 ( 5 ) : 1092-1100
-
8Buse JB, Henry RR, Hanj, et al. Effects of exenatide ( exendin-4) on glycemic control over 30 weeks in sulfonylurea- treated patients with type 2 diabetes [J]. Diabetes care, 2004,27 ( 11 ) :2628-2635
-
9Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea [ J ]. Diabetes care, 2005,28 ( 5 ) : 1093- 1901
-
10Bernard zinman, Byron J, Hoogwerf, et al. The effect of adding Exenatide to a Thiazolidinedione in suboptimally controlled Type 2 Diabetes [ J ]. Arm Intern Med , 2007, 146 (7) :477-485
共引文献14
-
1陈冰璞(综述),王建民(综述),徐春(审校).胰高血糖素样肽-1及其类似物在2型糖尿病治疗中的应用[J].武警医学,2009,20(3):275-276. 被引量:1
-
2王存川,黄璟.胃旁路手术治疗2型糖尿病[J].中华胃肠外科杂志,2009,12(6):549-550. 被引量:14
-
3陈侃.末段回肠移位术与2型糖尿病[J].中国老年学杂志,2011,31(2):360-361. 被引量:1
-
4李勋,魏寿江,沈俊,寇红艳,王崇树.胃转流术治疗2型糖尿病疗效观察——附17例报告[J].川北医学院学报,2011,26(1):14-15. 被引量:8
-
5林允信,许昌泰.胃旁路手术治疗2型糖尿病研究现状[J].医学综述,2011,17(6):902-905. 被引量:6
-
6赵伟.胰高血糖素样肽-1的研究进展[J].中国医药指南,2011,9(25):39-41. 被引量:1
-
7张秀娟,胡晶,吕梁,陈晓媛.艾塞那肽联合甘精胰岛素和门冬胰岛素联合甘精胰岛素在2型糖尿病治疗中的临床观察[J].国际老年医学杂志,2012,33(1):6-8. 被引量:2
-
8贺永刚,杨善智,尹家俊.胃旁路术治疗2型糖尿病研究进展[J].中华实用诊断与治疗杂志,2012,26(6):525-526. 被引量:1
-
9杨素兰,马波,武育卫,胡文华,孙高斌.57例2型糖尿病胃转流术后患者临床效果及管理现状分析[J].中国医师进修杂志,2012,35(19):14-17. 被引量:1
-
10李航,江小杰,吴黎敏.消化道不同重建方式对合并糖尿病胃癌患者术后血糖的影响[J].医学信息,2013(1):84-85. 被引量:1
同被引文献6
-
1Laurent Azoulay assistant professor,Hui Yin statistician,Kristian B Filion assistant professor,Jonathan Assayag graduate student,王子贤(编译).2型糖尿病患者服用吡格列酮的膀胱癌风险[J].中国处方药,2012,10(5):40-43. 被引量:18
-
2方福德.糖尿病分子遗传学与分子生物学研究的现状、问题、对策和展望[J].中国糖尿病杂志,2013,21(7):661-665. 被引量:9
-
3赵琳琳,郭珏函,夏雪,王守俊.利拉鲁肽对乳腺癌MCF-7细胞增殖影响的体外研究[J].医学研究生学报,2014,27(5):482-486. 被引量:11
-
4李锂,胡予.胰高血糖素样肽-2的生理功能和临床应用[J].中华消化杂志,2014,34(7):500-502. 被引量:3
-
5李小双,王中秋.胰腺癌与糖尿病的相关性及其影像学评价[J].医学研究生学报,2015,28(11):1223-1227. 被引量:7
-
6梁嘉琳,梁干雄.胰高血糖素与1型糖尿病关系的研究进展[J].医学研究生学报,2016,29(9):1004-1008. 被引量:7
-
1林琳,赵志泉,阎验,林征,张红杰.肠易激综合征与6种胃肠肽类激素的相关研究[J].胃肠病学,2003,8(B03):16-17. 被引量:1
-
2林琳,阎验,等.胃肠肽类激素与肠易激综合征的相关性[J].胃肠病学,2001,6(C00):76-76.
-
3陈胜良.胃肠肽类激素与炎症性肠病[J].国外医学(消化系疾病分册),2000,20(1):15-18.
-
4熊观瀛,林琳,赵志泉.P物质与肠易激综合征[J].国外医学(内科学分册),2003,30(6):245-248. 被引量:15
-
5任继平,王雁,王瑶,姜立萍,刘宁.十二指肠溃疡患者空腹血浆生长抑素及血管活性肠肽的变化[J].首都医科大学学报,2002,23(2):176-177.
-
6张红杰,林琳,赵志泉,阎验,林征,王美峰.胃肠肽类激素与肠易激综合征发病间的关系[J].南京医科大学学报(自然科学版),2003,23(6):527-529. 被引量:28
-
7金宇.胃泌素与胃动素在糖尿病研究中的意义[J].中医药学刊,2003,21(5):739-740. 被引量:7
-
8张心海.细胞信号转导与慢性胃炎[J].川北医学院学报,2004,19(3):199-201.
-
9陈寿坡.胃肠肽类激素与消化性溃疡[J].世界华人消化杂志,1998,6(S2):30-31. 被引量:1
-
10李颖,朱明辉.浅谈中医下法与胃肠肽类激素的关系[J].中医杂志,2008,49(12):1126-1128.